Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bovie Medical Corp (BVX) AMEX

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 96,803
  • Shares Outstanding, K 28,640
  • Annual Sales, $ 29,520 K
  • Annual Income, $ -5,370 K
  • 36-Month Beta -0.46
  • Price/Sales 2.73
  • Price/Book 4.65

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.58 +31.01%
on 02/02/17
3.95 -14.43%
on 01/23/17
-0.52 (-13.33%)
since 01/20/17
3-Month
2.58 +31.01%
on 02/02/17
4.48 -24.55%
on 11/22/16
-0.99 (-22.65%)
since 11/21/16
52-Week
1.56 +116.67%
on 05/23/16
5.75 -41.22%
on 10/31/16
+1.49 (+78.84%)
since 02/19/16

Most Recent Stories

More News
Why Bovie Medical (BVX) Could Be an Impressive Growth Stock

Bovie Medical (BVX) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective.

BVX : 3.38 (-3.43%)
Strength Seen in Bovie Medical (BVX): Stock Moves 5% Higher

Bovie Medical Corporation (BVX) was a big mover last session, as the company saw its shares rise around 5% on the day.

BVX : 3.38 (-3.43%)
CSII : 28.17 (-3.49%)
What Makes Meridian Bioscience (VIVO) a Strong Sell?

Meridian Bioscience (VIVO), has witnessed a significant price decline and negative trend in earnings estimate revisions

VIVO : 12.75 (unch)
BVX : 3.38 (-3.43%)
Bovie Medical Confirms Its 2017 Outlook

Bovie Medical Corporation (NYSE MKT:BVX) today reaffirmed its outlook for 2017.

BVX : 3.38 (-3.43%)
Bovie Medical Provides J-Plasma® Update

Bovie Medical Corporation (NYSE MKT: BVX), provided an update on its J-Plasma® product.

BVX : 3.38 (-3.43%)
Bovie Medical Appoints Eminent Gynecologic Oncologist to Medical Advisory Board

Bovie Medical Corporation ("Bovie" or the "Company") (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced today...

BVX : 3.38 (-3.43%)
Boston Scientific Down on Risks; Innovations Raise Hope

On Dec 27 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).

BVX : 3.38 (-3.43%)
BSX : 25.28 (-0.43%)
NXTM : 29.28 (-0.27%)
BAX : 49.96 (+0.46%)
Qiagen Poised on Fundamentals, Expansion Plans on Track

On Dec 23, 2016, we issued an updated research report on Netherlands-based molecular diagnostics provider Qiagen NV (QGEN).

BVX : 3.38 (-3.43%)
NXTM : 29.28 (-0.27%)
BAX : 49.96 (+0.46%)
QGEN : 28.74 (-0.52%)
Myriad Genetics: United Rheumatology Selects Vectra DA Test

Myriad Genetics, Inc.'s (MYGN) subsidiary, Crescendo Bioscience's Vectra DA assay has been added by United Rheumatology to its clinical practice guidelines for adults with rheumatoid arthritis.

BVX : 3.38 (-3.43%)
NXTM : 29.28 (-0.27%)
MYGN : 19.08 (+2.47%)
BAX : 49.96 (+0.46%)
Henry Schein Named 2016's Best Animal Healthcare Provider

Henry Schein, Inc. (HSIC) has been recognized as the "Best Animal Healthcare Product Provider 2016".

HSIC : 173.01 (+2.91%)
BVX : 3.38 (-3.43%)
NXTM : 29.28 (-0.27%)
BAX : 49.96 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devicesand advanced coating technologies.

See More

Support & Resistance

2nd Resistance Point 3.73
1st Resistance Point 3.56
Last Price 3.38
1st Support Level 3.27
2nd Support Level 3.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.